Countries Europe
Taiwan’s Formosa Pharmaceuticals Partners with Portugal’s DÁVI Farmacêutica to Introduce APP13007 for Post-Surgical Ocular Pain Relief in Europe
Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with DÁVI Far...
November 01, 2024 | News
Siemens Healthineers Expands Atellica Integrated Automation to Atellica CI Analyzer, Transforming Clinical Lab Operations
Siemens Healthineers is pleased to announce the expansion of its Atellica Integrated Automation solution to the Atellica CI Analyzer, bringing advanced aut...
October 31, 2024 | Product Spotlight
Australia's Telix Pharmaceuticals Partners with Subtle Medical for AI-Powered PET Imaging, Enhancing Illuccix® Efficiency and Patient Experience
Telix Pharmaceuticals announces a partnership with California-based Subtle Medical, Inc. (Subtle Medical) for artificial intelligence (AI)-powere...
October 31, 2024 | News
Pierre Fabre Doses First Patient with PFL-002/VERT-002, a Novel c-MET Degrader for MET-Altered Cancers
PFL-002/VERT-002 is a monoclonal antibody with a novel and differentiated mechanism of action, acting as a degrader of c-MET, with the potential to be...
October 25, 2024 | News
Angelini Pharma Secures Global and Asia Licensing Option for Brain Health Compound CV-01 in Partnership with Cureverse
The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel...
October 23, 2024 | News
SGS Launches Pioneering CDISC Open Rules Consultancy to Accelerate Clinical Trial Submissions
SGS, the world’s leading testing, inspection and certification company, has today launched its pioneering ‘CDISC Open Rules Consultancy’,...
October 23, 2024 | News
Recursion Doses First Patient in Phase 2 Trial of REC-3964, a Novel Non-Antibiotic Treatment for Recurrent C. difficile Infection
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a uni...
October 23, 2024 | News
Sanofi and CD&R Join Forces to Accelerate Opella’s Growth in Consumer Healthcare
Sanofi and Clayton, Dubilier & Rice (CD&R) announced exclusive negotiations for the transfer of a 50% controlling stake in Opella, Sanofi's consume...
October 22, 2024 | News
CSL Vifor and Travere Therapeutics Secure Swissmedic Approval for FILSPARI in Treatment of IgA Nephropathy
CSL Vifor and Travere Therapeutics, announced that Swissmedic has granted temporary marketing authorization for FILSPARI for the treatment of adults w...
October 18, 2024 | News
Isolere Bio by Donaldson Introduces Research-Grade IsoTag™ AAV Reagent for Superior Viral Vector Purification
Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of research-grade IsoTag™ AAV reagent, ...
October 18, 2024 | News
BD and Hamilton Collaborate to Streamline Genomic Sequencing with Automation-Ready Reagent Kits
Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing &nb...
October 15, 2024 | News
Thermo Fisher Introduces Iliad (S)TEM: Advancing Atomic-Level Insights with EELS and NanoPulser Technology
Thermo Scientific Iliad integrates electron energy loss spectroscopy (EELS) and NanoPulser electrostatic beam blanker to improve insights at the atomic lev...
October 15, 2024 | News
Leading Drug Discovery CRO NovAliX Partners with Bruker to Transform Therapeutic Innovation
Bruker Acquires Minority Stake in NovAliX in Strategic Move Partnership Leverages Synergies Between Premium Drug Discovery CRO and High-Value Life Scien...
October 11, 2024 | News
Astellas Secures Exclusive Option for AVB-101 Gene Therapy in $2.18 Billion Deal with AviadoBio
Astellas receives an exclusive option to license AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development Av...
October 11, 2024 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
